Age-Related Macular Degeneration (AMD) Treatment Market
According to Intent Market Research, the Age-Related Macular Degeneration Treatment Market is expected to grow from USD 11.1 billion in 2023 at a CAGR of 7.9% to touch USD 18.9 billion by 2030. The Age-Related Macular Degeneration Treatment Market is dominated by key players such as Regeneron Pharmaceuticals, Inc., Novartis AG, Bayer AG, Roche Holding AG, Pfizer Inc., Allergan (AbbVie), Kodiak Sciences Inc., Adverum Biotechnologies, Outlook Therapeutics, Inc., Ophthotech Corporation, Apellis Pharmaceuticals, Inc., Iveric Bio (formerly Ophthotech), Alimera Sciences, Graybug Vision, Inc., Biogen Inc.